United States - English - NLM (National Library of Medicine)

ventura corporation ltd. - octinoxate 7.0 % , oxybenzone 2.5 % - sunscreen - helps prevent sunburn

United States - English - NLM (National Library of Medicine)

ventura corporation ltd. - octinoxate 7.5%, octisalate 4%, octocrylene 10%, oxybenzone 6%, titanium dioxide 1% - sunscreen - helps prevent sunburn. - higher spf gives more sunburn protection. - provides high protection against sunburn - retains spf after 40 minutes of activity in the water.

United States - English - NLM (National Library of Medicine)

ventura international, limited - octinoxate 7.5%, octisalate 4%, octocrylene 10%, oxybenzone 6%, titanium dioxide 1% - sunscreen - helps prevent sunburn. - higher spf gives more sunburn protection. - provides high protection against sunburn - retains spf after 40 minutes of activity in the water.

European Union - English - EMA (European Medicines Agency)

intervet international bv - indoxacarb, permethrin - permethrin, combinations, ectoparasiticides for topical use, incl. insecticides - dogs - treatment of flea infestations (ctenocephalides felis); the product has persistent insecticidal efficacy for up to 4 weeks against ctenocephalides felis. the product has persistent acaricidal efficacy for up to 5 weeks against ixodes ricinus and up to 3 weeks against rhipicephalus sanguineus. one treatment provides repellent (anti-feeding) activity against sand flies (phlebotomus perniciosus) for up to 3 weeks.,

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - eprinomectin, fipronil, praziquantel, (s)-methoprene - antiparasitic products, insecticides and repellents, avermectins, eprinomectin, combinations, - cats - for cats with, or at risk from mixed infestations by cestodes, nematodes and ectoparasites. the veterinary medicinal product is exclusively indicated when all three groups are targeted at the same time.ectoparasitestreatment and prevention of infestations by fleas (ctenocephalides felis). elimination of fleas within 24 hours. one treatment prevents further infestations for at least one month.prevention of environmental flea contamination by inhibiting the development of flea immature stages (eggs, larvae and pupae) for over a month.the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).treatment and prevention of infestations by ticks (ixodes ricinus). elimination of ticks within 48 hours. one treatment prevents further infestations for up to 3 weeks.treatment of notoedric mange (notoedres cati).cestodestreatment of infestations with tapeworms (dipylidium caninum, taenia taeniaeformis, echinococcus multilocularis, joyeuxiella pasqualei (adult), and joyeuxiella fuhrmanni (adult)).nematodestreatment of infestations with gastrointestinal nematodes (l3, l4 larvae and adults of toxocara cati, adults of toxascaris leonina, l4 larvae and adults of ancylostoma tubaeforme and ancylostoma ceylanicum, and adults of ancylostoma brazilienze).treatment of infestations with feline lungworms (l3 larvae, l4 larvae and adults of aelurostrongylus abstrusus, l4 larvae and adults of troglostrongylus brevior).treatment of infestations with vesical worms (capillaria plica).prevention of heartworm disease (dirofilaria immitis larvae) for one month.

European Union - English - EMA (European Medicines Agency)

merial - fipronil, amitraz, (s)-methoprene - ectoparasiticides for topical use, incl. insecticides - dogs - treatment and prevention of infestations in dogs by ticks (ixodes ricinus, dermacentor reticulatus, rhipicephalus sanguineus, ixodes scapularis, dermacentor variabilis, haemaphysalis elliptica, haemaphysalis longicornis, amblyomma americanum and amblyomma maculatum) and fleas (ctenocephalides felis and ctenocephalides canis). treatment of infestations by chewing lice (trichodectes canis). prevention of environmental flea contamination by inhibiting the development of all flea immature stages. the product can be used as part of a treatment strategy for the control of flea-allergy dermatitis. elimination of fleas and ticks within 24 hours. one treatment prevents further infestations for five weeks by ticks and for up to five weeks by fleas.the treatment indirectly reduces the risk of transmission of tick-borne diseases (canine babesiosis, monocytic ehrlichiosis, granulocytic anaplasmosis and borreliosis) from infected ticks for four weeks.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner - isoxazolines, ectoparasiticides for systemic use - dogs - treatment of flea infestation in dogs (ctenocephalides felis and c. canis)  for at least 5 weeks. the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).treatment of tick infestation in dogs (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus). one treatment kills ticks for up to one month.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner, milbemycin oxime - endectocides, antiparasitic products, insecticides and repellents, milbemycin oxime, combinations - dogs - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum), thelaziosis (adult thelazia callipaeda) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks. treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis). treatment of demodicosis (caused by demodex canis). treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis). prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration. prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.prevention of establishment of thelaziosis (adult thelazia callipaeda eyeworm infection) with monthly administration.

European Union - English - EMA (European Medicines Agency)

elanco gmbh - pyriprole - ectoparasiticides for topical use, incl. insecticides - dogs - treatment and prevention of flea infestation (ctenocephalides canis and c. felis) in dogs. efficacy against new infestations with fleas persists for a minimum of 4 weeks.treatment and prevention of tick infestation (ixodes ricinus, rhipicephalus sanguineus, ixodes scapularis, dermacentor reticulatus, dermacentor variabilis, amblyomma americanum) in dogs. efficacy against ticks persists for 4 weeks.

European Union - English - EMA (European Medicines Agency)

pfizer limited  - metaflumizone, amitraz - ectoparasiticides for topical use, incl. insecticides - dogs - for the treatment and prevention of infestations by fleas (ctenocephalides canis and c. felis), and ticks (ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus, dermacentor reticulatus and dermacentor variabilis), and treatment of demodicosis (caused by demodex spp.) and lice (trichodectes canis) in dogs.the veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (fad).